Cresset Asset Management
MDT icon

Cresset Asset Management’s Medtronic MDT Stock Holding History

Cresset Asset Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-50,000
Closed -$4.41M – 1912
2023
Q2 		$4.41M Buy
+50,000
New +$4.3M 0.01% 446

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cresset Asset Management's MDT Position: Q2 2026 in Review

Cresset Asset Management increased its Medtronic (MDT) stake by 1.1% in Q2 2026, buying an estimated $183K and bringing the position to 201,891 shares worth $15.9M. The position accounts for 0.06% of the portfolio, ranked #197.

Cresset Asset Management first reported a position in MDT in Q4 2018 and has held it in 31 quarters since. The position peaked at $30.4M in Q3 2024. 2,148 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cresset Asset Management held 201,891 shares of Medtronic worth $15.9M as of Q2 2026.
  • Cresset Asset Management bought 2,265 Medtronic shares in Q2 2026, an estimated $183K.
  • Medtronic made up 0.06% of Cresset Asset Management's portfolio in Q2 2026, its #197 holding.
  • Cresset Asset Management first reported a position in Medtronic in Q4 2018 and has held it in 31 quarters since.
  • Cresset Asset Management's Medtronic position peaked at $30.4M in Q3 2024.
  • 2,148 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.